Sold as Butisol Sodium. Every FDA application for this active ingredient: 1 branded and 31 generic.
As of Nov 16, 2026, FDA lists 32 applications for Butabarbital Sodium (sold as Butisol Sodium), first approved Jun 5, 1939, with 0 new uses approved and 0 published complete response letters.
| Jun 5, 1939 | Butisol SodiumNDA 793 | Pharmobedient | 24 | Discontinued |
| Sep 25, 1973 | Sodium ButabarbitalANDA 83484 | Ivax Sub Teva Pharms | 0 | Discontinued |
| Jan 15, 1974 | Sodium ButabarbitalANDA 83524 | Marshall Pharma | 0 | Discontinued |
| Jan 28, 1974 | Butabarbital SodiumANDA 83337 | Whiteworth Town Plsn | 0 | Discontinued |
| Jan 29, 1974 | Butabarbital SodiumANDA 83325 | Whiteworth Town Plsn | 0 | Discontinued |
| Mar 14, 1974 | Sodium ButabarbitalANDA 83858 | Marshall Pharma | 0 | Discontinued |
| May 31, 1974 | Sodium ButabarbitalANDA 84040 | Ivax Sub Teva Pharms | 0 | Discontinued |
| Jun 14, 1974 | Butabarbital SodiumANDA 83606 | Solvay | 0 | Discontinued |
| Jun 21, 1974 | Butabarbital SodiumANDA 83896 | Solvay | 0 | Discontinued |
| Jun 21, 1974 | Butabarbital SodiumANDA 83897 | Solvay | 0 | Discontinued |
| Jun 21, 1974 | Butabarbital SodiumANDA 83898 | Solvay | 0 | Discontinued |
| Feb 11, 1976 | Sarisol No. 1, Sarisol No. 2ANDA 84719 | Halsey | 1 | Discontinued |
| Aug 15, 1977 | Sodium ButabarbitalANDA 85418 | Hikma | 6 | Discontinued |
| Aug 24, 1977 | Butabarbital SodiumANDA 85772 | Watson Labs | 0 | Discontinued |
| Oct 28, 1977 | Butabarbital SodiumANDA 85764 | Watson Labs | 0 | Discontinued |
| Dec 20, 1977 | Sodium ButabarbitalANDA 85432 | Hikma | 6 | Discontinued |
| Apr 10, 1978 | Butisol SodiumANDA 85380 | Meda Pharms | 17 | Discontinued |
| Apr 11, 1978 | ButicapsANDA 85381 | Medpointe Pharm Hlc | 0 | Discontinued |
| May 17, 1978 | ButabarbANDA 85873 | Alpharma US Pharms | 6 | Discontinued |
| May 31, 1978 | ButabarbitalANDA 85550 | Bundy | 0 | Discontinued |
| Jul 20, 1978 | Sodium ButabarbitalANDA 85866 | Lannett | 1 | Discontinued |
| Jul 20, 1978 | Sodium ButabarbitalANDA 85881 | Lannett | 1 | Discontinued |
| Aug 21, 1978 | Sodium ButabarbitalANDA 85849 | Lannett | 1 | Discontinued |
| Aug 30, 1978 | ButalanANDA 85880 | Lannett | 1 | Discontinued |
| Feb 26, 1979 | Butabarbital SodiumANDA 85383 | Wockhardt | 8 | Discontinued |
| Dec 1, 1981 | SarisolANDA 84723 | Halsey | 0 | Discontinued |
| Sep 16, 1994 | Butabarbital SodiumANDA 85934 | Sandoz | 3 | Discontinued |
| Sep 16, 1994 | Butabarbital SodiumANDA 85938 | Sandoz | 2 | Discontinued |
| — | Butabarbital SodiumANDA 84292 | Sandoz | 11 | Discontinued |
| — | Butabarbital SodiumANDA 88631 | Teva | 0 | Discontinued |
| — | Butabarbital SodiumANDA 88632 | Teva | 0 | Discontinued |
| — | Butabarbital SodiumANDA 84272 | Sandoz | 12 | Discontinued |
Applications, approvals and products come from FDA's Drugs@FDA data files, refreshed weekly, grouped by active ingredient as FDA spells it. Complete response letters are FDA's published letters. Medicare spending is CMS's Part D and Part B dashboard, matched to this ingredient by generic name; shortages are FDA's shortage list, matched by application number; clinical trials are ClinicalTrials.gov studies naming the ingredient as an intervention, refreshed daily; safety programs are FDA's REMS list, matched by application number or, for shared programs, by ingredient. Drugs@FDA